1. To analyse the clinically important Gram-negative isolates (Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa) and their susceptibility pattern in a tertiary care hospital; 2. To study the epidemiology of the isolates and sensitivity pattern of the Gram negative bacteria in a tertiary care hospital, Madurai, South Tamilnadu.
ESBLs are enzymes that mediate resistance to extendedspectrum (Third generation) Cephalosporins (e.g. Ceftazidime, Cefotaxime and Ceftriaxone) and Monobactams (e.g. Aztreonam), but do not affect Cephamycins (e.g. Cefoxitin and Cefotetan) or Carbapenems (e.g. Meropenem or Imipenem).
The prevalence of ESBL-producing bacteria have been gradually increasing in tertiary care hospitals according to a 2014 study by Joseph T. Spadafino et al. 3 ESBLproducing Escherichia coli was 69.4% in India. Concern has arisen in recent years over increasing rates of resistance to Carbapenems, as there are few therapeutic options for treating infections caused by Carbapenem-resistant bacteria. 4 Indian single centre studies showed a prevalence of Carbapenem resistance was 12-15% of Enterobacteriaceae. 5 Hence, the present study was conducted in Apollo Speciality Hospitals, Madurai, South India from January to December 2013-2015. The purpose of the study was to find out the prevalence of ESBL producers and Carbapenem resistance from the clinical isolates of Gram negative bacteria and also their susceptibility to commonly used antibiotics.
Antibiotics are tested according to CLSI guidelines and our own Antibiotic testing Policy. 
MATERIALS AND METHODS

METHODOLOGY
The antimicrobial susceptibility patterns of 6900 nonrepetitive isolates from 29,275 was studied. Samples such as Blood, Urine, Pus, Respiratory samples were collected from patients attending as outpatients and in different clinical departments, respective in patient wards and intensive care units by observing standard specimen collection procedure and aseptic precautions. The Gram Positive Cocci and Gram Negative bacterial isolates were 2357 and 4543. The clinically important Gram-negative isolates (Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa) and their susceptibility pattern was studied. Blood Samples were processed with Bactec System. Growth identified in Bactec system was streaked in MacConkey Agar and Blood Agar medium.
The other samples (Urine, pus, respiratory samples) were transported to the lab and streaked on MacConkey Agar and Blood Agar medium. After incubation for 18-24 hrs. at 37 o C, the culture plates were examined and bacterial isolates were observed by Gram Staining and motility test. The identification of bacteria was performed by standard protocol by observing MacConkey plates for Lactose/Non-lactose fermenters.
VITEK 2 was used to identify the bacteria and its susceptibility pattern. Antibiotics not included in Vitek 2 were processed by the disc diffusion method (Modified Kirby-Bauer method) using Mueller-Hinton agar.
The results were interpreted as per CLSI (Clinical and Laboratory Standards Institute) guidelines corresponding to that period. 6, 7 All antibiotic discs were obtained from 0  5  1  2  0  0  2  0  12   984  748  651  2383  100  104  89  89  282 100  325  417  232  974  100  0  281  323  903  100  4543   Table 2 : Number of Gram Negative Bacterial Isolates from Samples (2013-2015) n = 4543 Table 2 showed, the following isolates were isolated from urine, blood, pus and respiratory samples were 52%, 7%, 20%, 21%. Most common isolates in urine were E. coli (69%) and Klebsiella species (16%). Most common isolates in blood were E. coli (38%), Klebsiella species (25%) and Salmonella (13%). Most common isolates in respiratory samples were Klebsiella species (44%), Pseudomonas (28%) and E. coli (16%). Most common isolates in pus samples were E. coli (32%), Klebsiella species (23%) and Pseudomonas (27%). 
Antibiotics
Chart 1: Resistant Strains
Overall, ESBL strains increased from 64% to 66.3% in 2014, then decreased to 63.7% in 2015. Overall, carbapenem resistant strains increased from 2.4% to 3.8%. Resistant strains are identified with Vitek 2 from 2014 onwards.
Resistant strains are more prevalent in ICU, CCU and NICU.
DISCUSSION
This study revealed that Gram negative bacteria (65%) were more predominant than Gram positive bacteria (35%). Anitha et al 8 has reported the incidence of 80.96% for Gram-negative and 18% for Gram-positives. Gram negative bacterias were more isolated, which was correlated to present study.
In this study, most common isolates in urine were E. coli (69%) and Klebsiella species (16%), Namratha W Nandihal et al 9 showed Escherichia coli was the most commonly isolated bacteria and constituted 54.5%, which was followed by Klebsiella species of 21.5%. This study supports the findings of Namratha W Nandihal et al.
In this study, most common isolates in blood were E. coli (38%), Klebsiella species (25%) and Salmonella (13%). Shamim Mumtaz et al 10 showed in blood samples the most common organism isolated was E. coli followed by Salmonella and Klebsiella. This observation was similar to this study.
In this study, the most common isolates in respiratory samples were Klebsiella species (44%), Pseudomonas (28%) and E. coli (16%). Manikandan et al 11 showed the prevalence of bacteria spp. isolated were as follows: Klebsiella pneumoniae (38.4%), Pseudomonas aeruginosa (21%) and Escherichia coli (10%) which correlates with the present study.
In this study E. coli, Klebsiella species, Pseudomonas from urine, blood, respiratory samples, pus showed high sensitivity to Carbapenems, Piperacillin/Tazobactam, Cefoperazone/ Sulbactam and Aminoglycosides. This is in concordance with the study of Dinesh Kumar et al, 12 which showed analysis of antimicrobial susceptibility pattern of ESBL producing E. coli isolates from urine and blood demonstrated high susceptibility rates to Imipenem (100%, 100% 14 showed 100% sensitive to Imipenem and Meropenem among E. coli and Klebsiella spp. was detected. These observations were highly correlated with us.
In this study, in all samples E. coli isolates showed resistance to 3 rd generation Cephalosporins, Fluoroquinolones and Trimeth/Sulfonamides. Marwa E.A. Aly et al 15 showed 81-88% of MDR E. coli were resistant to Tetracycline, Fluoroquinolones and Sulfonamide/ Trimethoprim. This observation is similar to our study.
In this study, in all samples Klebsiella isolates showed resistance to 3 rd generation Cephalosporins, Trimeth/ Sulfonamides and Fluoroquinolones. Philippon A and Babini GS et al 16 showed that the ESBL Klebsiella was resistant to third generation Cephalosporins as well as the Aztreonam and Fluoroquinolones. This finding correlates with our study.
In this study in all samples Pseudomonas isolates showed resistance to Aminoglycosides, 3 rd generation Cephalosporins and Fluoroquinolones. Satyajeet K. Pawar et al 17 reported that around 70% of Pseudomonas strains were resistant to Aminoglycosides, Fluoroquinolones and 3rd generation Cephalosporins. This study highly correlates with our study.
In this study overall ESBL strains increased from 64% to 66.3% in 2014, then decreased to 63.7% in 2015. Mathai D et al 18 noted that the prevalence of ESBLs in India has now reached epidemic proportions, ranging from 62% to 100% in E. coli and Klebsiella spp. isolated from skin and soft tissue infections, blood stream infections and respiratory infections as observed in the 10 Indian medical centre SENTRY study. Our study highly correlates with Indian standards.
High percentage of ESBL producing E. coli has been reported with 60% in a study done at a tertiary care hospital in Chennai. 19 These findings correlates with our study.
In this study, overall Carbapenem resistant strains increased from 2.4% to 3.8%. Camilla Rodrigues 20 reported that a recent pilot study from a tertiary care centre in central Mumbai that receives referral samples from the city and the State found a steady increase in Carbapenem resistance in Enterobacteriaceae from 0% in 2006 to 8% in 2009.
CONCLUSION
In this 3 years study, we found that there was a progressive increase in antimicrobial resistance in isolates of E. coli, K. pneumoniae and P. aeruginosa isolated from blood, urine, pus and respiratory culture specimens. ESBL production was seen in the majority of isolates of E. coli and K. pneumoniae. Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa showed high sensitivity to Carbapenem and Piperacillin Tazobactam and Cefoperazone Tazobactam. Hence, for rational and judicial use of existing antibiotics, the Clinicians and Paramedical have to be sensitised with suitable awareness programmes and the present scenario to be brought to the notice of policy makers to formulate the policy and legislation for rational use of Antibiotics.
LIMITATIONS
This is a single centred study.
